Delivery Order SPE2DB20D3103-SPE2DB25FP7K4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.84 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive set-aside and is scheduled for completion by August 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $4,833.42, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,075.95 on July 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with an ultimate completion date of July 14, 2025. This is a firm fixed price, non-set-aside delivery order for pharmaceutical products to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,762.58 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,003.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen injectors on August 29, 2025, with completion scheduled for September 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order will be fulfilled at the contractor's...
- The Defense Logistics Agency awarded a $9,009.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7K4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,408.41 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on a firm fixed-price basis. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. The order represents a single transaction within the company's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency requirements and other federal healthcare systems worldwide. The Trulicity delivery fulfills the agency's need for diabetes medications as part of this broader military pharmaceutical supply program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/5/25 |